|
시장보고서
상품코드
2148322
Drug Discovery 분야 AI 시장 : 제공별, 기술별, Drug Discovery 프로세스별, 약물 유형별, 용도별, 최종사용자별, 지역별AI in Drug Discovery Market, By Offering, By Technology, By Drug Discovery Process, By Drug Type, By Application, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Drug Discovery 분야 AI 시장 규모는 2026년에 32억 4,000만 달러로 추정되며, 2033년까지 155억 3,620만 달러에 달할 것으로 전망됩니다. 2026년부터 2033년까지 CAGR 25.1%로 성장할 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 32억 4,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간의 CAGR: | 25.10% | 2033년 시장 규모 예측: | 155억 3,620만 달러 |
인공지능(AI)은 새로운 치료 화합물의 발굴, 개발 및 최적화를 가속화함으로써 제약 연구 분야의 신약 개발에 혁명을 일으키고 있습니다. 연구자들은 기계 학습, 딥러닝, 자연어 처리, 생성형 AI 기술을 활용하여 복잡한 생물학적 데이터 분석, 분자 간 상호작용 예측, 신약 개발 표적 식별, 그리고 가상 스크리닝 및 선도 화합물 최적화를 개선하고 있습니다.
AI는 유전체, 단백질, 바이오마커, 임상 데이터를 활용하여 신약 개발의 효율과 정확도를 향상시킬 수 있는 다차원적인 인사이트를 창출합니다. 제약 회사, 생명공학 기업, 연구 기관의 AI 기반 플랫폼 도입 확대는 보다 효율적인 신약 개발 워크플로우 구축으로 이어지며, 전 세계 Drug Discovery 분야 AI 시장의 성장을 뒷받침하고 있습니다.
시장 역학
세계 Drug Discovery 분야 AI 시장은 기존 신약 개발의 비용 증가와 복잡성 심화, 제약 업계의 연구개발비 증가, 그리고 유전체, 단백질체학, 화학 데이터의 양 증가에 힘입어 성장하고 있습니다. AI는 표적 식별, 가상 스크리닝, 선도 화합물 최적화, 약물 특성 예측과 같은 과정을 가속화하고 있습니다. 또한, 기술 기업과 제약 기업 간의 협력이 깊어짐에 따라 신약 개발 과정 전반에 걸쳐 AI 도입이 촉진되고 있습니다.
그러나 시장에는 표준화 문제, 데이터 개인정보 보호 및 지적 재산권에 대한 우려, 규제 측면의 불확실성, AI와 생명과학 분야의 전문 지식을 모두 갖춘 인재 부족 등 몇 가지 제약요인이 존재합니다. 그럼에도 불구하고, 데 노보 분자 설계를 위한 생성형 AI, AI를 활용한 희귀질환 치료법 개발, 그리고 아시아태평양 및 라틴아메리카와 같은 신흥 시장에서 AI 채택이 확대되는 데에는 큰 기회가 존재합니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 해설하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략과 같은 지표를 바탕으로 전 세계 Drug Discovery 분야 AI 시장의 주요 기업 개요를 소개하고 있습니다.
- 본 보고서에서 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 본 ‘세계 Drug Discovery 분야 AI 시장’ 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 Drug Discovery 분야 AI 시장을 분석하는 데 사용되는 다양한 전략 매트릭스를 활용하여 원활하게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 Drug Discovery 분야 AI 시장 : 제공별, 2021-2033년
제5장 세계의 Drug Discovery 분야 AI 시장 : 기술별, 2021-2033년
제6장 세계의 Drug Discovery 분야 AI 시장 : Drug Discovery 프로세스별, 2021-2033년
제7장 세계의 Drug Discovery 분야 AI 시장 : 약물 유형별, 2021-2033년
제8장 세계의 Drug Discovery 분야 AI 시장 : 용도별, 2021-2033년
제9장 세계의 Drug Discovery 분야 AI 시장 : 최종사용자별, 2021-2033년
제10장 세계의 Drug Discovery 분야 AI 시장 : 지역별, 2021-2033년
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고문헌 및 조사 방법
KSM 26.10.22AI in Drug Discovery Market is estimated to be valued at USD 3,240.0 Mn in 2026 and is expected to reach USD 15,536.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 25.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3,240.0 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 25.10% | 2033 Value Projection: | USD 15,536.2 Mn |
Artificial intelligence (AI) is revolutionizing drug discovery in pharmaceutical research by accelerating the identification, development and optimization of novel therapeutic compounds. Researchers are using machine learning, deep learning, natural language processing, and generative AI techniques to analyze complex biological data, predict molecular interactions, identify drug targets, and improve virtual screening and lead optimization.
AI leverages genomic, protein, biomarker and clinical data to generate multidimensional insights that may improve the efficiency and accuracy of drug discovery. The increasing adoption of AI-driven platforms by pharmaceutical companies, biotech firms and research institutes is leading to the creation of more efficient discovery workflows and fueling the expansion of the Global AI in Drug Discovery Market.
Market Dynamics
The global AI in drug discovery market is driven by the escalating cost and complexity of traditional drug discovery, increasing pharmaceutical R&D expenditure, and the mounting volume of genomic, proteomic, and chemical data. AI is accelerating processes such as target identification, virtual screening, lead optimization, and drug property prediction. Furthermore, the increasing collaborations between technology and pharmaceutical companies are fueling the adoption of AI across the drug discovery process.
However, a number of constraints are present in the market, such as standardization issues, data privacy and intellectual property concerns, regulatory uncertainty, and a shortage of professionals with combined AI and life sciences expertise. Nevertheless, significant opportunities exist in generative AI for de novo molecule design, AI-enabled development of therapies for rare diseases, and growing adoption in emerging markets such as Asia-Pacific and Latin America.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global AI in drug discovery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Schrodinger, Inc., Insilico Medicine, Recursion Pharmaceuticals, Inc., Isomorphic Labs Limited, XtalPi Inc., insitro, Inc., BenevolentAI, Generate Biomedicines, Inc., Owkin, Inc., and Atomwise, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global AI in drug discovery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global AI in drug discovery market
Market Segmentation
- Offering Insights (Revenue, USD Mn, 2021 - 2033)
- Software
- Services
- Technology Insights (Revenue, USD Mn, 2021 - 2033)
- Machine Learning
- Deep Learning
- Generative AI
- Natural Language Processing
- Others
- Drug Discovery Process Insights (Revenue, USD Mn, 2021 - 2033)
- Target Identification and Validation
- Hit Identification and Screening
- Lead Identification and Optimization
- Preclinical Development
- Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
- Small-Molecule Drugs
- Large-Molecule Drugs
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Drug Repurposing
- De Novo Drug Design
- Virtual Screening
- Biomarker Discovery
- Others
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutes
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Schrodinger, Inc.
- Insilico Medicine
- Recursion Pharmaceuticals, Inc.
- Isomorphic Labs Limited
- XtalPi Inc.
- insitro, Inc.
- BenevolentAI
- Generate Biomedicines, Inc.
- Owkin, Inc.
- Atomwise, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global AI in Drug Discovery Market, By Offering
- Global AI in Drug Discovery Market, By Technology
- Global AI in Drug Discovery Market, By Drug Discovery Process
- Global AI in Drug Discovery Market, By Drug Type
- Global AI in Drug Discovery Market, By Application
- Global AI in Drug Discovery Market, By End User
- Global AI in Drug Discovery Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Offering Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Industry Trends
4. Global AI in Drug Discovery Market, By Offering, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global AI in Drug Discovery Market, By Technology, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Machine Learning
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Deep Learning
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Generative AI
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Natural Language Processing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global AI in Drug Discovery Market, By Drug Discovery Process, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Target Identification and Validation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Hit Identification and Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Lead Identification and Optimization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Preclinical Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global AI in Drug Discovery Market, By Drug Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Small-Molecule Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Large-Molecule Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global AI in Drug Discovery Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Drug Repurposing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- De Novo Drug Design
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Virtual Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Biomarker Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global AI in Drug Discovery Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
10. Global AI in Drug Discovery Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Schrodinger, Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
- Insilico Medicine
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
- Recursion Pharmaceuticals, Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
- Isomorphic Labs Limited
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
- XtalPi Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
- insitro, Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
- BenevolentAI
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
- Generate Biomedicines, Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
- Owkin, Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
- Atomwise, Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
